ALBINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 948
EU - Europa 673
AS - Asia 211
AF - Africa 3
OC - Oceania 2
Totale 1.837
Nazione #
US - Stati Uniti d'America 947
DE - Germania 321
CN - Cina 109
UA - Ucraina 90
GB - Regno Unito 89
RU - Federazione Russa 80
SG - Singapore 49
FI - Finlandia 41
HK - Hong Kong 34
IT - Italia 17
IE - Irlanda 14
TR - Turchia 12
BE - Belgio 7
FR - Francia 6
IN - India 4
CZ - Repubblica Ceca 3
AU - Australia 2
RO - Romania 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 1.837
Città #
Fairfield 173
Woodbridge 123
Houston 92
Ashburn 67
Seattle 67
Jacksonville 65
Cambridge 50
Wilmington 47
Chandler 42
Ann Arbor 40
Singapore 39
Hong Kong 34
Helsinki 27
Princeton 26
Lancaster 23
Nanjing 23
New York 20
Dublin 14
Nanchang 14
Beijing 13
Nürnberg 13
Istanbul 12
San Diego 10
Brussels 7
Changsha 7
Moscow 7
Tianjin 7
Dearborn 6
Des Moines 6
Shanghai 6
Falkenstein 5
Hebei 5
London 5
Shenyang 5
Brescia 4
Jiaxing 4
Ningbo 4
Verona 4
Jinan 3
Milan 3
Taiyuan 3
Boardman 2
Brno 2
Changchun 2
Hangzhou 2
Kunming 2
Lanzhou 2
Orange 2
Taizhou 2
Washington 2
Abidjan 1
Amsterdam 1
Carhaix 1
Chicago 1
Chiswick 1
Cleveland 1
Clifton 1
Corinella 1
Guangzhou 1
Lappeenranta 1
Los Angeles 1
Mexico City 1
Minsk 1
Monmouth Junction 1
Munich 1
New Bedfont 1
Olomouc 1
Perth 1
Redmond 1
San Mateo 1
Surabaya 1
Taipei 1
Warsaw 1
Totale 1.166
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 197
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 163
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 160
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 151
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 148
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 144
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 143
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 140
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 139
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 137
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons 125
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 104
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 99
Reply to van der Pas et al 19
Totale 1.869
Categoria #
all - tutte 7.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020237 0 0 0 0 0 0 57 56 48 51 4 21
2020/2021213 4 39 4 21 14 32 7 23 25 19 18 7
2021/2022143 7 41 0 1 2 1 9 5 5 25 9 38
2022/2023129 13 2 0 3 16 36 0 14 29 1 8 7
2023/2024126 6 6 10 17 7 25 8 3 25 1 0 18
2024/2025102 3 1 0 28 17 39 14 0 0 0 0 0
Totale 1.869